![Aaron Deykin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Aaron Deykin
Directeur Technique/Scientifique/R&D chez
UPSTREAM BIO, INC.
Fortune : 277 527 $ au 31/05/2026
Profil
Aaron Deykin is currently an Independent Director at GentiBio, Inc. and Chief Medical Officer, Head of Research & Development at Upstream Bio, Inc. Formerly, Dr. Deykin was Director of Late Stage Neurology Development at Biogen, Inc. from 2020 to 2022, Assistant Professor at Harvard Medical School, and a Member at Brigham & Womens Hospital.
Education includes undergraduate studies at Dartmouth College and a doctorate from Harvard Medical School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
UPSTREAM BIO, INC. 0,06% | 16/06/2026 | 33 197 ( 0,06% ) | 277 527 $ | 31/05/2026 |
Postes actifs de Aaron Deykin
| Sociétés | Poste | Début |
|---|---|---|
| UPSTREAM BIO, INC. | Directeur Technique/Scientifique/R&D | 01/04/2022 |
GentiBio, Inc.
 GentiBio, Inc. BiotechnologyHealth Technology Develops regulatory T-cells for allergic diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Aaron Deykin
| Sociétés | Poste | Fin |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/04/2022 |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Formation de Aaron Deykin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
13
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GentiBio, Inc.
GentiBio, Inc. BiotechnologyHealth Technology Develops regulatory T-cells for allergic diseases | Health Technology |
Upstream Bio, Inc.
 Upstream Bio, Inc. BiotechnologyHealth Technology Engages in developing treatments for inflammatory diseases | Health Technology |
Choisissez Zonebourse 
